FDA Investigator Lisa R Hilliar
Lisa R Hilliar has inspections in 4 countries as of 08 Dec 2023. Lisa R Hilliar has collaborated with a combined 1811 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
21
Last Inspection Date:
08 Dec 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Country:
United States of America,
Japan,
India,
Israel
Co-Investigator(s):
Aditi S Thakur,
Alan M Barker,
Allison C Hunter,
Andrea A Branche,
Andrew J Barrowcliff,
Anna M Brannen,
Bei Y He,
Brenda C Hamilton,
Carl Lee,
Cassandra L Abellard,
CDR Rochelle B Young, RPh, MSA,
Charisse K Green,
Charles L Zhou,
Christina L Bigham,
Christopher T Middendorf,
Claire M Minden,
Constantin Y Philopoulos,
D Yvette Barnett,
David S Jackson,
Dipesh K Shah,
Dr. Carmelo Rosa,
Dr. Robert C Horan, MD,
Dyvette Arline,
Elizabeth Ll Edwards,
Gayle S Lawson,
Genevieve E Ghand,
Geoffrey K Kilili,
Gretchen Lf Trendel,
Heather A Mccauley,
Hector A Carrero,
Isabel Y Espinosa,
James C Maclaughlin,
James Norman,
Jamie L Dion,
Javonica F Penn,
Jeffrey D Meng,
Jennifer L Gustavus,
Jessica L Pressley,
Jill R Loeliger,
Jill R Raezer,
Jon P Antoniou,
Jose E Melendez, DDC,
Joseph A Piechocki,
Joshua P Wireman,
Joshua S Hunt,
Juan Rjimenez Garcia,
Junho Pak,
Kathleen D Culver,
Kathleen Dant Ceckner,
Kenneth E Felkley,
Kenneth H Williams,
Kham Phommachanh,
Lauren N Howard,
Lauren N Smith,
Lianji Jin,
Linda F Murphy,
Lindsey M Schwierjohann,
Logan T Williams,
Luis M Burgos Medero,
Marcellinus D Dordunoo,
Margaret M Annes,
Maribeth G Grattan,
Mark E Parmon,
Matthew B Casale,
Megan T Ziegler,
Michael C Zubelewicz,
Michael P Sheehan,
Michele L Forster, PhD,
Muralidhara B Gavini, PhD,
Nadeem I Chaudhry,
Nibin Varghese, MS,
Nicholas J Presto,
Nicholas L Paulin,
Nimmy Mathews,
Nina Ni,
Ou Ma,
Paranthaman Senthamaraikannan,
Peter E Baker,
Rafeeq A Habeeb,
Rebecca E Dombrowski,
Robert J Ham,
Roy C Stephens,
Samantha J Bradley,
Sena G Dissmeyer,
Senz G Dissmeyer,
Steven P Eastham,
Susan M Jackson,
Sydney S Choi,
Tamil Arasu, PhD,
Teresa K Kastner,
Thomas J Arista,
Tiara M Brown,
Tracey L Harris,
Vaishali J Patel,
Walden H Lee,
Wayne D Mcgrath,
Wen Ning Chan (Sally),
Wendy G Tan, PhD,
Zachary L Miller
Lisa R Hilliar's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more